The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)
Open accessAbstract
As the coronavirus disease 19 (COVID-19) global pandemic rages across the globe, the race to prevent and treat this deadly disease has led to the “off-label” repurposing of drugs such as hydroxychloroquine and lopinavir/ritonavir, which have the potential for unwanted QT-interval prolongation and a risk of drug-induced sudden cardiac death. With the possibility that a considerable proportion of the world’s population soon could receive COVID-19 pharmacotherapies with torsadogenic potential for therapy or postexposure prophylaxis, this document serves to help health care professionals mitigate the risk of drug-induced ventricular arrhythmias while minimizing risk of COVID-19 exposure to personnel and conserving the limited supply of personal protective equipment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gautret, P., Lagier, J.-C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187
Yao, X., Ye, F., Zhang, M., Cui, C., Huang, B., Niu, P., Liu, X., Zhao, L., Dong, E., Song, C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa237 · Cited by 2,662
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Vincent, M. J., Bergeron, E., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,811
Effects of chloroquine on viral infections: an old drug against today's diseases
Savarino, A., Boelaert, J. R., Cassone, A., Majori, G., & Cauda, R. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00806-5 · Cited by 1,268
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Colson, P., Rolain, J.-M., Lagier, J.-C., Brouqui, P., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105932 · Cited by 937 · cited 1×
“5, 6 In light of (1) the need for this practice to continue in the absence of viable, evidence-based therapies and (2) the proclivity of many promising COVID-19 pharmacotherapiesdspecifically antimalarial agents such as hydroxychloroquinedto prolong the QTc, thereby increasing the risk of drug-induced torsades de poin…”
International Recommendations for Electrocardiographic Interpretation in Athletes
Sharma, S., Drezner, J. A., Baggish, A., Papadakis, M., Wilson, M. G., Prutkin, J. M., La Gerche, A., Ackerman, M. J., Borjesson, M., Salerno, J. C., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.015 · Cited by 598
Self-citationIn vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds
Chen, F., Chan, K. H., Jiang, Y., Kao, R. Y. T., Lu, H. T., Fan, K. W., Cheng, V. C. C., Tsui, W. H. W., Hung, I. F. N., & Lee, T. S. W. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.03.003 · Cited by 534
International recommendations for electrocardiographic interpretation in athletes
Sharma, S., Drezner, J. A., Baggish, A., Papadakis, M., Wilson, M. G., Prutkin, J. M., La Gerche, A., Ackerman, M. J., Borjesson, M., Salerno, J. C., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehw631 · Cited by 424
Self-citationSauer, A. J., Moss, A. J., McNitt, S., Peterson, D. R., Zareba, W., Robinson, J. L., Qi, M., Goldenberg, I., Hobbs, J. B., Ackerman, M. J., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.057 · Cited by 419
Self-citationLong QT syndrome: reduced repolarization reserve and the genetic link
RODEN, D. M. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01589.x · Cited by 322
Risk of Aborted Cardiac Arrest or Sudden Cardiac Death During Adolescence in the Long-QT Syndrome
Hobbs, J. B., Peterson, D. R., Moss, A. J., McNitt, S., Zareba, W., Goldenberg, I., Qi, M., Robinson, J. L., Sauer, A. J., Ackerman, M. J., et al. (2006) · JAMA · doi:10.1001/jama.296.10.1249 · Cited by 313
Self-citationGoldenberg, I., Moss, A. J., Peterson, D. R., McNitt, S., Zareba, W., Andrews, M. L., Robinson, J. L., Locati, E. H., Ackerman, M. J., Benhorin, J., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.701243 · Cited by 304
Self-citationChronic Hydroxychloroquine Use Associated with QT Prolongation and Refractory Ventricular Arrhythmia
Chen, C.-Y., Wang, F.-L., & Lin, C.-C. (2006) · Clinical Toxicology · doi:10.1080/15563650500514558 · Cited by 270
Vink, A. S., Neumann, B., Lieve, K. V. V., Sinner, M. F., Hofman, N., el Kadi, S., Schoenmaker, M. H. A., Slaghekke, H. M. J., de Jong, J. S. S. G., Clur, S.-A. B., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.033943 · Cited by 176
Institution-Wide QT Alert System Identifies Patients With a High Risk of Mortality
Haugaa, K. H., Bos, J. M., Tarrell, R. F., Morlan, B. W., Caraballo, P. J., & Ackerman, M. J. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.01.013 · Cited by 163
Self-citationInhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells
Traebert, M., Dumotier, B., Meister, L., Hoffmann, P., Dominguez-Estevez, M., & Suter, W. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.11.003 · Cited by 159
GARABELLI, P., STAVRAKIS, S., ALBERT, M., KOOMSON, E., PARWANI, P., CHOHAN, J., SMITH, L., ALBERT, D., XIE, R., XIE, Q., et al. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12976 · Cited by 98
Guide to Understanding the 2019 Novel Coronavirus
Shah, A., Kashyap, R., Tosh, P. K., Sampathkumar, P., & O’Horo, J. C. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.02.003 · Cited by 92
Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations
Soliman, E. Z., Lundgren, J. D., Roediger, M. P., Duprez, D. A., Temesgen, Z., Bickel, M., Shlay, J. C., Somboonwit, C., Reiss, P., Stein, J. H., et al. (2010) · AIDS · doi:10.1097/qad.0b013e328341dcc0 · Cited by 73
Giudicessi, J. R., Noseworthy, P. A., & Ackerman, M. J. (2019) · Circulation · doi:10.1161/circulationaha.119.039598 · Cited by 67
Self-citationCardiovascular safety of prokinetic agents: A focus on drug‐induced arrhythmias
Giudicessi, J. R., Ackerman, M. J., & Camilleri, M. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13302 · Cited by 66
Self-citationAzithromycin and risk of sudden cardiac death: Guilty as charged or falsely accused?
Giudicessi, J. R., & Ackerman, M. J. (2013) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.80a.13077 · Cited by 51
Self-citationArellano‐Rodrigo, E., García, A., Mont, L., & Roqué, M. (2001) · Medicina Clínica · doi:10.1016/s0025-7753(01)72036-2 · Cited by 47
Cited by
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Vogel, B., Acevedo, M., Appelman, Y., Bairey Merz, C. N., Chieffo, A., Figtree, G. A., Guerrero, M., Kunadian, V., Lam, C. S. P., Maas, A. H. E. M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00684-x · Cited by 1,488
Impact of sex and gender on COVID-19 outcomes in Europe
Gebhard, C., Regitz-Zagrosek, V., Neuhauser, H. K., Morgan, R., & Klein, S. L. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00304-9 · Cited by 1,306
Mehra, M. R., Desai, S. S., Ruschitzka, F., & Patel, A. N. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31180-6 · Cited by 1,200
RetractedConsiderations for Drug Interactions on QTc in Exploratory COVID-19 Treatment
Roden, D. M., Harrington, R. A., Poppas, A., & Russo, A. M. (2020) · Circulation · doi:10.1161/circulationaha.120.047521 · Cited by 779
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome
Hendren, N. S., Drazner, M. H., Bozkurt, B., & Cooper, L. T. (2020) · Circulation · doi:10.1161/circulationaha.120.047349 · Cited by 576
Metadata
- Authors
- Giudicessi, J. R., Noseworthy, P. A., Friedman, P. A., & Ackerman, M. J.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 95
- Issue
- 6
- Pages
- 1213-1221
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W3015907249
- Cited by
- 394
- References
- 26
- FWCI
- 52.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.